Abstract:The ECM (extracellular matrix) network plays a crucial role in cardiac homeostasis, not only by providing structural support, but also by facilitating force transmission, and by transducing key signals to cardiomyocytes, vascular cells, and interstitial cells. Changes in the profile and biochemistry of the ECM may be critically implicated in the pathogenesis of both heart failure with reduced ejection fraction and heart failure with preserved ejection fraction. The patterns of molecular and biochemical ECM alterations in failing hearts are dependent on the type of underlying injury. Pressure overload triggers early activation of a matrix-synthetic program in cardiac fibroblasts, inducing myofibroblast conversion, and stimulating synthesis of both structural and matricellular ECM proteins. Expansion of the cardiac ECM may increase myocardial stiffness promoting diastolic dysfunction. Cardiomyocytes, vascular cells and immune cells, activated through mechanosensitive pathways or neurohumoral mediators may play a critical role in fibroblast activation through secretion of cytokines and growth factors. Sustained pressure overload leads to dilative remodeling and systolic dysfunction that may be mediated by changes in the interstitial protease/antiprotease balance. On the other hand, ischemic injury causes dynamic changes in the cardiac ECM that contribute to regulation of inflammation and repair and may mediate adverse cardiac remodeling. In other pathophysiologic conditions, such as volume overload, diabetes mellitus, and obesity, the cell biological effectors mediating ECM remodeling are poorly understood and the molecular links between the primary insult and the changes in the matrix environment are unknown. This review article discusses the role of ECM macromolecules in heart failure, focusing on both structural ECM proteins (such as fibrillar and nonfibrillar collagens), and specialized injury-associated matrix macromolecules (such as fibronectin and matricellular proteins). Understanding the role of the ECM in heart failure may identify therapeutic targets to reduce geometric remodeling, to attenuate cardiomyocyte dysfunction, and even to promote myocardial regeneration.

Extracellular Matrix Interactome in Modulating Vascular Homeostasis and Remodeling

Extracellular matrix dynamics in vascular remodeling

Vascular wall extracellular matrix proteins and vascular diseases

Vascular Extracellular Matrix Remodeling and Hypertension

Vascular Extracellular Matrix in Atherosclerosis

The extracellular matrix mechanics in the vasculature

The Extracellular Matrix in Ischemic and Nonischemic Heart Failure

The Role of Matrix Proteins in Cardiac Pathology

ECM Microenvironment in Vascular Homeostasis: New Targets for Atherosclerosis

[Extracellular Matrix, Matrix-Degrading Proteases and Vascular Calcification].

The Extracellular Matrix: Its Composition, Function, Remodeling, and Role in Tumorigenesis

A guide to the composition and functions of the extracellular matrix

Structural extracellular matrix-mediated molecular signaling in wound repair and tissue regeneration

Matrix Metalloproteinases: Inflammatory Regulators of Cell Behaviors in Vascular Formation and Remodeling

Emerging Role of Exosome-Mediated Intercellular Communication in Vascular Remodeling

Extracellular matrix remodeling and cardiac fibrosis

Mechanisms of assembly and remodelling of the extracellular matrix

Extracellular Matrix and Cytokines: A Functional Unit

Extracellular Matrix-Based Biomaterials for Cardiovascular Tissue Engineering

Macrophages and the Extracellular Matrix

Interplay Between Extracellular Matrix and Neutrophils in Diseases